Multi-Plaintiff N.Y. Federal Lipitor Action Dismissed on Preemption Grounds



DOCUMENTS
  • Order


NEW YORK — A New York federal judge has dismissed a multi-plaintiff Lipitor injury action, ruling that the claims are preempted because the plaintiffs failed to plausibly allege the existence of newly acquired information that could have justified revision of the drug’s label.

In an April 7 order, Senior Judge William H. Pauley III of the U.S. District Court for the Southern District of New York further ruled that the claims are untimely under the state’s one-year statute of limitations.

On April 15, 2019, 24 plaintiffs filed the instant action in the New York County Supreme Court, alleging their …






UPCOMING CONFERENCES




HarrisMartin's MDL Conference: The Current Mass Tort Landscape - Best Management Practices & Updates on Key Litigation

September 28, 2022 - St. Louis, MO
Four Seasons Hotel, St. Louis

MORE DETAILS



HarrisMartin’s Webinar Series: Acetaminophen ASD/ADHD Product Liability Litigation

October 21, 2022

MORE DETAILS